Beyond consultancy, proven to deliver.

Orphan Drug Consultancy provides end-to-end management and technical support to pharmaceutical and biopharmaceutical companies launching new products globally.

The right expertise. Right when you need it.

Our team consists of trusted advisors—industry-leading subject matter experts (SMEs) and professionals—who provide consulting services to innovative pharmaceutical and biotech companies.

Supported over 70+ Pharma and Biopharma Companies

100+ Combined Successful Global Country Launches

Supported over 70+ Pharma and Biopharma Companies

Supported over 70+ Pharma and Biopharma Companies

quote

What our clients say

Case Study

Navigating the landscape of bringing a product to your patient

Navigating the landscape of bringing a product to your patient

Lorem ipsum dolor sit amet consectetur. Massa eu dignissim et mollis ac. Sed felis sed pellentesque eu viverra interdum facilisis sit. Leo lacus pharetra ut tortor condimentum sed mauris a. Suspendisse quam arcu nullam pretium nibh sit elementum duis quisque.

Resources

For Industry Leaders

A comprehensive collection of insights and guidance on key topics within the pharmaceutical and biotech industries, providing the expertise and knowledge to maker informed decisions.
Pioneering Operational Clarity to Power Growth in Orphan Drugs
Navigating Brexit’s Impact on EU Pharma: Insights from Our Recent Event in Boston
Melbourne 2023
CPHI Barcelona 2023 
World Orphan Drug Congress Europe 2023
Swiss Biotech Day 2023
World Orphan Drug Congress USA 2023
BIO International Convention 2023
J.P. Morgan Healthcare Week 2023
Orphan Drugs & Rare Diseases Global Congress 2022 Americas
European Supply Strategy Workshop
Orphan Drug Consulting Celebrates 5 Years in Business with Key Milestone Achievements in 2022
World Orphan Drug Congress Europe 2022
Pharma Integrates 2022
Orphan Drug Consulting Further Expands into the US Market with Key Personnel Relocation to Boston, MA
Orphan Drug Consulting Appoint Mike Gannon as Chief Financial Officer
AusBiotech 2022
CPhI Worldwide 2022
Orphan Drug Consulting Appoint Anne Capplis as Lead Consultant for the Asia Pacific Region
Orphan Drug Consulting Appoint David McGovern as a Supply Chain Consultant
Orphan Drug Consulting Appoint Martina White and Nicola Martone as Quality Consultants
World Orphan Drug Congress USA 2022
Almac Product Launch Success Workshop
Orphan Drug Consulting Appoint Frances Pierce as Head of Supply Chain
BIO International Convention 2022
Bio Integrates 2022
Orphan Drug Consulting CEO and Founder Evelyn Kelly selected for the EY Entrepreneur of the Year Programme 2022
Product Launch Planning Workshop
Orphan Drug Consulting Appoint Sharon Cullen as Head of Quality
Orphan Drug Consulting Celebrates Four Years in Business
World Orphan Drug Congress 2021
CPhI Worldwide 2021
Orphan Drug Consulting Appoint Jason Cameron as Chief Operating Officer
EMA Labelling and Packaging Regulations
EU Marketing Authorization Procedures
Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, or Go Hybrid?
Acting as a Responsible Person (import) (RPI) in the UK
Webinar: Launching an RX Product in the EU
BREXIT: Approved Country Lists Post-Transition Period
Orphan Drug Consulting Appoint Grainne Higgins as Human Resources Consultant
Orphan Drug Consulting Appoint Mike Gannon as Financial and Entity Planning Consultant
Orphan Drug Consulting Open Office in Boston, MA, and Appoint Christy Webb as US-based Consultant
Orphan Drug Consulting Appoint Tanya Quinn as US-based Consultant
Pharmaceutical Business Continuity Plan as a Key Component of COVID-19 Pandemic Response
EU Regulatory Flexibility During COVID-19 Pandemic
EU-GMP Guideline of Annex 21 ‘Importation of Medicinal Products’
The Impact of Coronavirus (SARS-CoV-2) and COVID-19 on Global Pharmaceutical Supply Chains with Focus on the Indian and Chinese Markets
Rare Diseases Day 2020: The Importance of Orphan Drugs in Combating Rare Diseases
Advanced Therapy Medicinal Products (ATMPs)
Brexit